Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Malignant Lymphoma

  Free Subscription


06.04.2026

1 Am J Hematol
2 Blood
2 BMC Cancer
1 Br J Haematol
5 Haematologica
1 J Clin Oncol
2 Leuk Lymphoma


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Hematol

  1. KHURANA A, Hayashi H, Thach B, Yang ZZ, et al
    High Soluble Tumor Necrosis Factor Receptor 2 in Serum Is Associated With Inferior Overall Survival Across Major Lymphoma Subtypes.
    Am J Hematol. 2026 Mar 27. doi: 10.1002/ajh.70293.
    PubMed         Abstract available


    Blood

  2. ROBERTZ AS, Buhnen I, Meissner J, Trautmann-Grill K, et al
    Gonadal Function and Fertility after Hodgkin Lymphoma Treatment with Nivolumab-AVD in the Phase II GHSG NIVAHL Trial.
    Blood. 2026 Apr 2:blood.2025031809. doi: 10.1182/blood.2025031809.
    PubMed         Abstract available

  3. GOWER N, Feugier P, Westin JR, Schiano de Colella JS, et al
    Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis.
    Blood. 2026 Mar 31:blood.2026033126. doi: 10.1182/blood.2026033126.
    PubMed         Abstract available


    BMC Cancer

  4. ANDERA LF, Chetty DR, Mohamed Z, Oelofse D, et al
    Real-world lymphoma cohort in an HIV-endemic setting: cohort design, epidemiological features and impact of implementing novel classification standards.
    BMC Cancer. 2026 Apr 2. doi: 10.1186/s12885-026-15807.
    PubMed        

  5. SUN J, Xu Y, Zheng X, Wang H, et al
    ZR2-miniCHOP for elderly patients with newly diagnosed diffuse large B-cell lymphoma.
    BMC Cancer. 2026 Apr 1. doi: 10.1186/s12885-026-15896.
    PubMed        


    Br J Haematol

  6. CASERTA S, Martino EA, Skafi M, Alvaro ME, et al
    Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integration.
    Br J Haematol. 2026 Mar 29. doi: 10.1111/bjh.70458.
    PubMed         Abstract available


    Haematologica

  7. SHUMILOV E, Wurm-Kuczera R, Kauer J, Wang M, et al
    Outcomes of real-world complete responders after fixed-duration glofitamab in relapsed/refractory large B-cell lymphoma.
    Haematologica. 2026 Apr 2. doi: 10.3324/haematol.2025.300063.
    PubMed         Abstract available

  8. ILAN U, Boer JM, Luesink M, Bautista F, et al
    First-year results of the International Leukemia/Lymphoma Target Board for pediatric relapsed and refractory hematological malignancies.
    Haematologica. 2026 Apr 2. doi: 10.3324/haematol.2025.300154.
    PubMed         Abstract available

  9. ORTIZ CR, Abouzeid H, De Bernardi C, Durham A, et al
    Azacitidine-induced remission enables allogeneic transplantation in TET2/BCOR-mutant relapsed extranodal natural killer/T-cell lymphoma: a case report.
    Haematologica. 2026 Apr 2. doi: 10.3324/haematol.2025.300314.
    PubMed         Abstract available

  10. HWANG A, Kirkwood AA, Hardefeldt P, Amrith M, et al
    CAR-T therapy for relapsed/refractory large B-cell lymphoma in people living with HIV: efficacy, toxicity and treatment considerations.
    Haematologica. 2026 Apr 2. doi: 10.3324/haematol.2025.300151.
    PubMed         Abstract available

  11. ABEYAKOON C, Kuruvilla J
    Relapsed classic Hodgkin lymphoma; should all patients receive an autologous stem cell transplant? - the PRO.
    Haematologica. 2026 Apr 2. doi: 10.3324/haematol.2026.300574.
    PubMed         Abstract available


    J Clin Oncol

  12. PEMMARAJU N, Marconi G, Montesinos P, Lane AA, et al
    Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm.
    J Clin Oncol. 2026;44:861-873.
    PubMed         Abstract available


    Leuk Lymphoma

  13. NAKAMURA D, Ueno T, Nakabeppu SI, Shyodai A, et al
    Validation of prognostic indices in adult T-cell leukemia/lymphoma and their prognostic value at the start of second-line treatment.
    Leuk Lymphoma. 2026 Apr 1:1-7. doi: 10.1080/10428194.2026.2645946.
    PubMed         Abstract available

  14. TAKAHASHI H, Nakajima Y, Kaburaki T, Hamada T, et al
    Efficacy of CD19 CAR T-cell therapy in active vitreoretinal lymphoma.
    Leuk Lymphoma. 2026 Mar 31:1-4. doi: 10.1080/10428194.2026.2650671.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum